An AI tool using stimulated Raman histology can predict sites of glioblastoma recurrence before they appear on MRI.
Key Details
- 1AI model combines imaging, clinical, and molecular data to predict glioblastoma recurrence locations.
- 2Developed using 300 samples from 60 patients; validated on 100 samples from 20 patients.
- 3Utilizes stimulated Raman histology (SRH) to produce rapid, dye-free microscopic images of brain tissue.
- 4AI-based tumor infiltration score matched conventional pathology in predicting recurrences.
- 5Combined model outperformed individual methods, distinguishing tissue likely to recur within 5-10mm accuracy.
- 6Findings published in Science Advances by UC San Francisco and University of Michigan.
Why It Matters
Early and accurate prediction of glioblastoma recurrence sites enables more targeted therapies and may improve patient outcomes. This research highlights the growing synergy between rapid intraoperative imaging and AI for real-time decision-making in neuro-oncology.
Source
EurekAlert
Related News
•EurekAlert
Mayo Clinic AI Model Predicts Pancreatic Cancer Risk Years Before Diagnosis
An AI model developed at Mayo Clinic accurately predicts pancreatic cancer risk up to three years before diagnosis using longitudinal health data.
•EurekAlert
MD Anderson AI Flags Lung Cancer Patients at High Pneumonitis Risk Using CT Scans
MD Anderson researchers developed an AI model that predicts which lung cancer patients may develop serious immunotherapy-induced pneumonitis using routine CT scans.
•EurekAlert
AI Model Predicts Organ Failure from CT in Pancreatitis Hours in Advance
A multicenter deep learning model (ORACLE) predicts organ failure in acute pancreatitis from CT scans with high accuracy, outperforming existing clinical tools.